Categories Wellness-Health

Vitamin Supplements Recalled in Over 20 States

An active recall has been issued for a liquid multivitamin supplement sold in 24 states and territories due to contamination concerns, as announced by federal regulators.

The U.S. Food and Drug Administration classified this action as a Class II recall on Tuesday, citing concerns that the product may contain “black particulate matter” or a “foreign object.”

A Class II recall indicates that consuming the affected product could lead to temporary or medically reversible health issues.

This recall, issued by Miami-based Llorens Pharmaceuticals International Division, Inc., affects over 4,000 units of the Nephronex multivitamin supplement, which is an 8-fluid-ounce liquid formula containing vitamin B-complex, vitamin C, and folic acid.

According to a consumer alert issued by the California State Board of Pharmacy, the affected bottles carry the lot code “B2025” and an expiration date of “08/27.”

More than 4,000 units of Nephronex liquid multivitamin are included in the active recall. The affected 8-fluid-ounce bottles contain vitamin B-complex, vitamin C, and folic acid
More than 4,000 units of Nephronex liquid multivitamin are included in the active recall. The affected 8-fluid-ounce bottles contain vitamin B-complex, vitamin C, and folic acid (Getty Images)

The Independent has contacted Llorens Pharmaceuticals for comment.

Regulators noted that the product was distributed between February 2026 and May 2026 in states including Arizona, California, Colorado, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Massachusetts, Minnesota, Missouri, New Jersey, New York, North Carolina, Ohio, Oklahoma, Puerto Rico, Tennessee, Texas, Virginia, Washington, West Virginia, and Wisconsin.

Health officials are urging consumers who have this product to stop using it immediately. The multivitamin should either be disposed of or returned to the place of purchase for a refund. Individuals who experience any health issues after using the supplement are advised to seek medical attention.

For more information regarding the recall, consumers can contact the FDA at 1-888-463-6332.

Leave a Reply

您的邮箱地址不会被公开。 必填项已用 * 标注

You May Also Like